Product approval information is indicated for:
o The management of allograft rejection in renal transplant patients.
o The treatment of moderate to severe aplastic anemia in patients who are unsuitable for bone marrow transplantation.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/s5kBcIE
No comments:
Post a Comment